These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 24679693)

  • 1. Does residual aortic regurgitation after transcatheter aortic valve implantation increase mortality in all patients? The importance of baseline natriuretic peptides.
    Borz B; Durand E; Godin M; Tron C; Canville A; Hauville C; Bauer F; Cribier A; Eltchaninoff H
    Int J Cardiol; 2014 May; 173(3):436-40. PubMed ID: 24679693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different impact of aortic regurgitation assessed by aortic root angiography after transcatheter aortic valve implantation according to baseline left ventricular ejection fraction and N-terminal pro-B-type natriuretic peptide.
    Kaneko H; Hoelschermann F; Schau T; Tambor G; Neuss M; Butter C
    Cardiovasc Interv Ther; 2018 Jul; 33(3):232-238. PubMed ID: 28567700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early changes in N-terminal pro-B-type natriuretic peptide levels after transcatheter aortic valve replacement and its impact on long-term mortality.
    Liebetrau C; Gaede L; Kim WK; Arsalan M; Blumenstein JM; Fischer-Rasokat U; Wolter JS; Kriechbaum S; Huber MT; van Linden A; Berkowitsch A; Dörr O; Nef H; Hamm CW; Walther T; Möllmann H
    Int J Cardiol; 2018 Aug; 265():40-46. PubMed ID: 29885699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term prognostic value and serial changes of plasma N-terminal prohormone B-type natriuretic peptide in patients undergoing transcatheter aortic valve implantation.
    Ribeiro HB; Urena M; Le Ven F; Nombela-Franco L; Allende R; Clavel MA; Dahou A; Côté M; Laflamme J; Laflamme L; DeLarochellière H; DeLarochellière R; Doyle D; Dumont E; Bergeron S; Pibarot P; Rodés-Cabau J
    Am J Cardiol; 2014 Mar; 113(5):851-9. PubMed ID: 24528616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolution and prognostic value of N-terminal brain natriuretic peptide in predicting 1-year mortality in patients following transcatheter aortic valve implantation.
    Elhmidi Y; Bleiziffer S; Piazza N; Ruge H; Krane M; Deutsch MA; Hettich I; Voss B; Mazzitelli D; Lange R
    J Invasive Cardiol; 2013 Jan; 25(1):38-44. PubMed ID: 23293174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and prognostic value of N-terminal pro B-type natriuretic peptide (NT-proBNP) in patients with chronic aortic regurgitation.
    Weber M; Hausen M; Arnold R; Moellmann H; Nef H; Elsaesser A; Mitrovic V; Hamm C
    Int J Cardiol; 2008 Jul; 127(3):321-7. PubMed ID: 18055041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of 1-year mortality in patients with aortic regurgitation after transcatheter aortic valve implantation: an analysis from the multicentre German TAVI registry.
    Abdel-Wahab M; Zahn R; Gerckens U; Linke A; Sievert H; Schäfer U; Kahlert P; Hambrecht R; Sack S; Hoffmann E; Senges J; Schneider S; Richardt G;
    Heart; 2014 Aug; 100(16):1250-6. PubMed ID: 24895354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of paravalvular leaks on biomarkers and survival after transcatheter aortic valve implantation.
    Schewel D; Frerker C; Schewel J; Wohlmuth P; Meincke F; Thielsen T; Kreidel F; Kuck KH; Schäfer U
    Catheter Cardiovasc Interv; 2015 Feb; 85(3):502-14. PubMed ID: 24259366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aortic regurgitation after transcatheter aortic valve implantation with balloon- and self-expandable prostheses: a pooled analysis from a 2-center experience.
    Abdel-Wahab M; Comberg T; Büttner HJ; El-Mawardy M; Chatani K; Gick M; Geist V; Richardt G; Neumann FJ;
    JACC Cardiovasc Interv; 2014 Mar; 7(3):284-92. PubMed ID: 24650401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Device-dependent association between paravalvar aortic regurgitation and outcome after TAVI.
    Dworakowski R; Wendler O; Halliday B; Ludman P; DeBelder M; Ray S; Moat N; Kovac J; Spyt T; Trivedi U; Hildick-Smith D; Blackman D; Marlee D; Cunningham D; MacCarthy PA
    Heart; 2014 Dec; 100(24):1939-45. PubMed ID: 25053724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact and natural history of postprocedural aortic regurgitation on early and midterm mortality following transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis.
    Ielasi A; Latib A; Sacco FM; Costopoulos C; Figini F; Grimaldi A; Naim C; Maisano F; Chieffo A; Montorfano M; Alfieri O; Colombo A
    J Cardiovasc Med (Hagerstown); 2015 Apr; 16(4):286-95. PubMed ID: 25643194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-procedural N-terminal pro-brain natriuretic peptide predicts one-year mortality after transcatheter aortic valve implantation.
    Vale NC; Campante Teles R; Madeira S; Brito J; Sousa Almeida M; Nolasco T; Abecasis J; Rodrigues G; Carmo J; Furstenau M; Ribeiras R; Neves JP; Mendes M
    Rev Port Cardiol (Engl Ed); 2018 Jan; 37(1):67-73. PubMed ID: 29317115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of N-terminal pro-B-type natriuretic peptide response on long-term prognosis after transcatheter aortic valve implantation for severe aortic stenosis and heart failure.
    Kaneko H; Hoelschermann F; Tambor G; Okamoto M; Neuss M; Butter C
    Heart Vessels; 2019 May; 34(5):777-783. PubMed ID: 30443765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-year evolution of mild aortic regurgitation following transcatheter aortic valve implantation: early insights from a single-centre experience.
    Buzzatti N; Castiglioni A; Agricola E; Barletta M; Stella S; Giannini F; Regazzoli D; Mangieri A; Ancona M; Spagnolo P; Chieffo A; Montorfano M; Alfieri O; Colombo A; Latib A
    Interact Cardiovasc Thorac Surg; 2017 Jul; 25(1):75-82. PubMed ID: 28379385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recovery of left ventricular mechanics after transcatheter aortic valve implantation: effects of baseline ventricular function and postprocedural aortic regurgitation.
    Poulin F; Carasso S; Horlick EM; Rakowski H; Lim KD; Finn H; Feindel CM; Greutmann M; Osten MD; Cusimano RJ; Woo A
    J Am Soc Echocardiogr; 2014 Nov; 27(11):1133-42. PubMed ID: 25125314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of tricuspid regurgitation and new pacemaker implantation in patients undergoing transcatheter aortic valve implantation.
    Schewel D; Schewel J; Schlüter M; Kreidel F; Schmidt T; Schmoeckel M; Elsässer A; Kuck KH; Frerker C
    Int J Cardiol; 2018 Jun; 261():37-41. PubMed ID: 29572082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic implications of N-terminal pro-B-type natriuretic peptide in patients with normal left ventricular ejection fraction undergoing transcatheter aortic valve implantation.
    Seoudy H; Kuhn C; Frank J; Eden M; Rangrez AY; Lutter G; Frey N; Frank D
    Int J Cardiol; 2020 Feb; 301():195-199. PubMed ID: 31757644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of aortic regurgitation after TAVI in patients with chronic kidney disease.
    Possner M; Vontobel J; Nguyen-Kim TD; Zindel C; Holy EW; Stämpfli SF; Zuber M; Kaufmann PA; Nietlispach F; Maisano F; Niemann M; Tanner FC
    Int J Cardiol; 2016 Oct; 221():180-7. PubMed ID: 27404672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of patients with moderate and severe prosthetic aortic valve regurgitation after transcatheter aortic valve implantation.
    Gotzmann M; Korten M; Bojara W; Lindstaedt M; Rahlmann P; Mügge A; Ewers A
    Am J Cardiol; 2012 Nov; 110(10):1500-6. PubMed ID: 22863177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is elevation of N-terminal pro-B-type natriuretic peptide at discharge associated with 2-year composite endpoint of all-cause mortality and heart failure hospitalisation after transcatheter aortic valve implantation? Insights from a multicentre prospective OCEAN-TAVI registry in Japan.
    Mizutani K; Hara M; Nakao M; Okai T; Kajio K; Murakami T; Shibata T; Yoshiyama M; Naganuma T; Yamanaka F; Higashimori A; Tada N; Takagi K; Araki M; Ueno H; Tabata M; Shirai S; Watanabe Y; Yamamoto M; Hayashida K
    BMJ Open; 2018 Aug; 8(8):e021468. PubMed ID: 30121598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.